Trends in Kinase Selectivity: Insights for Target Class-Focused Library Screening-Reference-Cited by-同舟云学术

Trends in Kinase Selectivity: Insights for Target Class-Focused Library Screening

Published:2010-12-03 Issue:1 Volume:54 Page:54-66
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Posy Shana L.¹,Hermsmeier Mark A.²,Vaccaro Wayne³,Ott Karl-Heinz⁴,Todderud Gordon⁵,Lippy Jonathan S.⁵,Trainor George L.³,Loughney Deborah A.¹,Johnson Stephen R.¹

Affiliation:

1. Computer-Assisted Drug Design, Applied Biotechnology, Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States

2. Chemistry Informatics, Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States

3. Discovery Chemistry, Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States

4. Bioinformatics, Applied Biotechnology, Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States

5. Lead Evaluation, Applied Biotechnology, Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm101195a

Reference45 articles.

1. The Protein Kinase Complement of the Human Genome

2. High Affinity Targets of Protein Kinase Inhibitors Have Similar Residues at the Positions Energetically Important for Binding

3. Studies leading to the identification of ZD1839 (iressa™): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer

4. BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of SILA-123 as a Highly Potent FLT3 Inhibitor for the Treatment of Acute Myeloid Leukemia with Various FLT3 Mutations;Journal of Medicinal Chemistry;2024-09-11

2. Screening Ultra-Large Encoded Compound Libraries Leads to Novel Protein–Ligand Interactions and High Selectivity;Journal of Medicinal Chemistry;2024-01-10

3. Target Class Profiling of Small-Molecule Methyltransferases;ACS Chemical Biology;2023-03-28

4. Lead Generation;The Handbook of Medicinal Chemistry;2023-02-03

5. An open source plant kinase chemogenomics set;Plant Direct;2022-11